Alcon Inc

ALCNYSE · USD
65.26USD0.00 (+1.23%)
695

Alcon Inc (ALC) Covered Calls

As of September 28, 2026, ALC has 110 covered call opportunities in the coming three months. Return ranges from 2.6 to 102.0% until expiration. Annualized return ranges from 11.5 to 182.8%. The nearest expiration is October 16, 2026. Maximum potential profit is $6,578.

Read more

Running ALC covered calls helps you generate consistent income from Alcon Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Alcon Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best ALC covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if ALC stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling ALC covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Alcon Inc covered call is worth writing.

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery.

Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Income-focused investors, long-term ALC holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling ALC covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Alcon Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryMedical Instruments & Supplies
  • SectorHealthcare
  • IV percentile55.16% Neutral
  • Market cap (M$)31,462
  • 52 weeks high-25.54%
  • 52 weeks low5.53%
  • Analyst recommendationBuy
    1.82
  • Target price$85.54
    31.08% above the current stock price
  • Dividend—
  • Payout ratio16.97%
  • Earnings date2026-11-10
  • P/E50.04
  • Future P/E16.51
  • EPS (ttm)1.30
  • EPS growth next 5 years13.35%

As of September 28, 2026

2026-11-205682.5027.970.050.301808.0028.04182.79-0.08+0.0590.25
2026-11-205680.0024.090.100.351563.0024.24158.02-0.16+0.063240.25
2026-12-188487.5035.720.050.252308.0035.80155.56-0.08+0.04960.20
2026-10-162170.008.580.100.25563.008.73151.78-0.16+0.10830.15
2027-01-1511292.5043.480.050.252808.0043.56141.94-0.08+0.03260.20
2026-12-188485.0031.840.100.302063.0032.00139.04-0.16+0.05230.20
2027-02-19147100.0055.110.050.253558.0055.19137.03-0.08+0.0300.20
2026-11-205677.5020.210.150.401318.0020.44133.25-0.23+0.081050.25
2027-01-1511290.0039.600.050.252558.0039.68129.31-0.08+0.041510.20
2026-12-188482.5027.970.150.351818.0028.20122.53-0.23+0.061110.20

As of September 28, 2026

Sell covered calls with the data behind you

Find the best ALC covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial